Cargando…
Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia
INTRODUCTION: The idea that multidrug resistance (MDR) to antibiotics in pathogens causing ventilator-associated pneumonia (VAP) is an independent risk factor for adverse outcome is still debated. We aimed to identify the determinants of MDR versus non-MDR microbial aetiology in VAP and assessed whe...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646301/ https://www.ncbi.nlm.nih.gov/pubmed/19014695 http://dx.doi.org/10.1186/cc7119 |
_version_ | 1782164841566306304 |
---|---|
author | Depuydt, Pieter O Vandijck, Dominique M Bekaert, Maarten A Decruyenaere, Johan M Blot, Stijn I Vogelaers, Dirk P Benoit, Dominique D |
author_facet | Depuydt, Pieter O Vandijck, Dominique M Bekaert, Maarten A Decruyenaere, Johan M Blot, Stijn I Vogelaers, Dirk P Benoit, Dominique D |
author_sort | Depuydt, Pieter O |
collection | PubMed |
description | INTRODUCTION: The idea that multidrug resistance (MDR) to antibiotics in pathogens causing ventilator-associated pneumonia (VAP) is an independent risk factor for adverse outcome is still debated. We aimed to identify the determinants of MDR versus non-MDR microbial aetiology in VAP and assessed whether MDR versus non-MDR VAP was independently associated with increased 30-day mortality. METHODS: We performed a retrospective analysis of a prospectively registered cohort of adult patients with microbiologically confirmed VAP, diagnosed at a university hospital intensive care unit during a three-year period. Determinants of MDR as compared with non-MDR microbial aetiology and impact of MDR versus non-MDR aetiology on mortality were investigated using multivariate logistic and competing risk regression analysis. RESULTS: MDR pathogens were involved in 52 of 192 episodes of VAP (27%): methicillin-resistant Staphylococcus aureus in 12 (6%), extended-spectrum β-lactamase producing Enterobacteriaceae in 28 (15%), MDR Pseudomonas aeruginosa and other non-fermenting pathogens in 12 (6%). Multivariable logistic regression identified the Charlson index of comorbidity (odds ratio (OR) = 1.38, 95% confidence interval (CI) = 1.08 to 1.75, p = 0.01) and previous exposure to more than two different antibiotic classes (OR = 5.11, 95% CI = 1.38 to 18.89, p = 0.01) as predictors of MDR aetiology. Thirty-day mortality after VAP diagnosis caused by MDR versus non-MDR was 37% and 20% (p = 0.02), respectively. A multivariate competing risk regression analysis showed that renal replacement therapy before VAP (standardised hazard ratio (SHR) = 2.69, 95% CI = 1.47 to 4.94, p = 0.01), the Charlson index of comorbidity (SHR = 1.21, 95% CI = 1.03 to 1.41, p = 0.03) and septic shock on admission to the intensive care unit (SHR = 1.86, 95% CI = 1.03 to 3.35, p = 0.03), but not MDR aetiology of VAP, were independent predictors of mortality. CONCLUSIONS: The risk of MDR pathogens causing VAP was mainly determined by comorbidity and prior exposure to more than two antibiotics. The increased mortality of VAP caused by MDR as compared with non-MDR pathogens was explained by more severe comorbidity and organ failure before VAP. |
format | Text |
id | pubmed-2646301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26463012009-02-24 Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia Depuydt, Pieter O Vandijck, Dominique M Bekaert, Maarten A Decruyenaere, Johan M Blot, Stijn I Vogelaers, Dirk P Benoit, Dominique D Crit Care Research INTRODUCTION: The idea that multidrug resistance (MDR) to antibiotics in pathogens causing ventilator-associated pneumonia (VAP) is an independent risk factor for adverse outcome is still debated. We aimed to identify the determinants of MDR versus non-MDR microbial aetiology in VAP and assessed whether MDR versus non-MDR VAP was independently associated with increased 30-day mortality. METHODS: We performed a retrospective analysis of a prospectively registered cohort of adult patients with microbiologically confirmed VAP, diagnosed at a university hospital intensive care unit during a three-year period. Determinants of MDR as compared with non-MDR microbial aetiology and impact of MDR versus non-MDR aetiology on mortality were investigated using multivariate logistic and competing risk regression analysis. RESULTS: MDR pathogens were involved in 52 of 192 episodes of VAP (27%): methicillin-resistant Staphylococcus aureus in 12 (6%), extended-spectrum β-lactamase producing Enterobacteriaceae in 28 (15%), MDR Pseudomonas aeruginosa and other non-fermenting pathogens in 12 (6%). Multivariable logistic regression identified the Charlson index of comorbidity (odds ratio (OR) = 1.38, 95% confidence interval (CI) = 1.08 to 1.75, p = 0.01) and previous exposure to more than two different antibiotic classes (OR = 5.11, 95% CI = 1.38 to 18.89, p = 0.01) as predictors of MDR aetiology. Thirty-day mortality after VAP diagnosis caused by MDR versus non-MDR was 37% and 20% (p = 0.02), respectively. A multivariate competing risk regression analysis showed that renal replacement therapy before VAP (standardised hazard ratio (SHR) = 2.69, 95% CI = 1.47 to 4.94, p = 0.01), the Charlson index of comorbidity (SHR = 1.21, 95% CI = 1.03 to 1.41, p = 0.03) and septic shock on admission to the intensive care unit (SHR = 1.86, 95% CI = 1.03 to 3.35, p = 0.03), but not MDR aetiology of VAP, were independent predictors of mortality. CONCLUSIONS: The risk of MDR pathogens causing VAP was mainly determined by comorbidity and prior exposure to more than two antibiotics. The increased mortality of VAP caused by MDR as compared with non-MDR pathogens was explained by more severe comorbidity and organ failure before VAP. BioMed Central 2008 2008-11-17 /pmc/articles/PMC2646301/ /pubmed/19014695 http://dx.doi.org/10.1186/cc7119 Text en Copyright © 2008 Depuydt et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Depuydt, Pieter O Vandijck, Dominique M Bekaert, Maarten A Decruyenaere, Johan M Blot, Stijn I Vogelaers, Dirk P Benoit, Dominique D Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia |
title | Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia |
title_full | Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia |
title_fullStr | Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia |
title_full_unstemmed | Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia |
title_short | Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia |
title_sort | determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646301/ https://www.ncbi.nlm.nih.gov/pubmed/19014695 http://dx.doi.org/10.1186/cc7119 |
work_keys_str_mv | AT depuydtpietero determinantsandimpactofmultidrugantibioticresistanceinpathogenscausingventilatorassociatedpneumonia AT vandijckdominiquem determinantsandimpactofmultidrugantibioticresistanceinpathogenscausingventilatorassociatedpneumonia AT bekaertmaartena determinantsandimpactofmultidrugantibioticresistanceinpathogenscausingventilatorassociatedpneumonia AT decruyenaerejohanm determinantsandimpactofmultidrugantibioticresistanceinpathogenscausingventilatorassociatedpneumonia AT blotstijni determinantsandimpactofmultidrugantibioticresistanceinpathogenscausingventilatorassociatedpneumonia AT vogelaersdirkp determinantsandimpactofmultidrugantibioticresistanceinpathogenscausingventilatorassociatedpneumonia AT benoitdominiqued determinantsandimpactofmultidrugantibioticresistanceinpathogenscausingventilatorassociatedpneumonia |